Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Targeting Inflammation in Cancer Prevention and Therapy.

Todoric J, Antonucci L, Karin M.

Cancer Prev Res (Phila). 2016 Dec;9(12):895-905. Epub 2016 Nov 10. Review.

PMID:
27913448
2.

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.

Rahman S, Pierce Campbell CM, Rollison DE, Wang W, Waterboer T, Michel A, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Giuliano AR.

PLoS One. 2016 Nov 30;11(11):e0167173. doi: 10.1371/journal.pone.0167173. eCollection 2016.

3.

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.

Ferns DM, Heeren AM, Samuels S, Bleeker MCG, de Gruijl TD, Kenter GG, Jordanova ES.

J Immunother Cancer. 2016 Nov 15;4:78. doi: 10.1186/s40425-016-0184-3. eCollection 2016.

4.

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.

Veluchamy JP, Heeren AM, Spanholtz J, van Eendenburg JD, Heideman DA, Kenter GG, Verheul HM, van der Vliet HJ, Jordanova ES, de Gruijl TD.

Cancer Immunol Immunother. 2017 Jan;66(1):51-61. doi: 10.1007/s00262-016-1919-1. Epub 2016 Oct 25.

5.

HPV Vaccination: Attitude and Knowledge among German Gynecologists.

Kolben TM, Dannecker C, Baltateanu K, Goess C, Starrach T, Semmlinger A, Ditsch N, Gallwas J, Mahner S, Friese K, Kolben T.

Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1074-1080.

6.

p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.

Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W.

Oncotarget. 2016 Oct 4;7(40):64810-64819. doi: 10.18632/oncotarget.11705.

7.

Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.

Borena W, Grünberger M, Widschwendter A, Kraxner KH, Marth E, Mayr P, Meier J, Ruth N, Guerrero AT, Marth C, Holm-von Laer D.

BMC Public Health. 2016 Aug 26;16:889. doi: 10.1186/s12889-016-3581-0.

8.

Design and efficacy of a multilingual, multicultural HPV vaccine education intervention.

Valdez A, Stewart SL, Tanjasiri SP, Levy V, Garza A.

J Commun Healthc. 2015;8(2):106-118. Epub 2015 Jul 8.

9.

HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data.

Martins TR, Mendes de Oliveira C, Rosa LR, de Campos Centrone C, Rodrigues CL, Villa LL, Levi JE.

Virol J. 2016 Aug 12;13:138. doi: 10.1186/s12985-016-0594-3.

10.

Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M.

J Med Virol. 2016 Nov;88(11):1944-52. doi: 10.1002/jmv.24555. Epub 2016 May 9.

11.

Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.

Shaw E, Ramanakumar AV, El-Zein M, Silva FR, Galan L, Baggio ML, Villa LL, Franco EL; Ludwig-McGill Cohort Study.

BMC Infect Dis. 2016 Mar 8;16:116. doi: 10.1186/s12879-016-1446-x.

12.

Estimates and determinants of HPV non-vaccination and vaccine refusal in girls 12 to 14 y of age in Canada: Results from the Childhood National Immunization Coverage Survey, 2013.

Gilbert NL, Gilmour H, Dubé È, Wilson SE, Laroche J.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1484-90. doi: 10.1080/21645515.2016.1153207. Epub 2016 Mar 4.

13.

Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence.

Yang DX, Soulos PR, Davis B, Gross CP, Yu JB.

Am J Clin Oncol. 2016 Jan 22. [Epub ahead of print]

14.

Human Papillomavirus Infection and Vaccination: Awareness and Knowledge of HPV and Acceptability of HPV Vaccine among Mothers of Teenage Daughters in Weihai, Shandong, China.

Yu Y, Xu M, Sun J, Li R, Li M, Wang J, Zhang D, Xu A.

PLoS One. 2016 Jan 14;11(1):e0146741. doi: 10.1371/journal.pone.0146741. eCollection 2016.

15.

HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.

Zang B, Huang G, Wang X, Zheng S.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13687-94. eCollection 2015.

16.

Human papillomavirus variants among Inuit women in northern Quebec, Canada.

Gauthier B, Coutlée F, Franco EL, Brassard P.

Int J Circumpolar Health. 2015 Dec 9;74:29482. doi: 10.3402/ijch.v74.29482. eCollection 2015.

17.

Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.

Trottier H, Mayrand MH, Baggio ML, Galan L, Ferenczy A, Villa LL, Franco EL; Ludwig-McGill Cohort Study Group.

BMC Pregnancy Childbirth. 2015 Oct 7;15:244. doi: 10.1186/s12884-015-0675-0.

19.

Molecular cancer prevention: Current status and future directions.

Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET.

CA Cancer J Clin. 2015 Sep-Oct;65(5):345-83. doi: 10.3322/caac.21287. Epub 2015 Aug 18. Review.

20.

HPV Carcinomas in Immunocompromised Patients.

Reusser NM, Downing C, Guidry J, Tyring SK.

J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260. Review.

Supplemental Content

Support Center